Children to recover quickly after Multisystem inflammatory syndrome from covid-19

Published On 2022-01-25 15:05 GMT   |   Update On 2022-01-25 15:06 GMT

Children have better recuperating ability than adults, their growing nature makes them much stronger to several diseases. Covid-19 infected kids also showed better recovery rate than adults. Heart function recovery returned within three months in children who developed COVID-19-related multisystem inflammatory syndrome (MIS-C), according to new research published today in the Journal of...

Login or Register to read the full article

Children have better recuperating ability than adults, their growing nature makes them much stronger to several diseases. Covid-19 infected kids also showed better recovery rate than adults.

Heart function recovery returned within three months in children who developed COVID-19-related multisystem inflammatory syndrome (MIS-C), according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

MIS-C is a new illness identified during the COVID-19 pandemic that affects children about four to six weeks after exposure to COVID-19. The new condition has some overlapping symptoms with Kawasaki disease, however, MIS-C is associated with more profound inflammation. MIS-C can cause inflammation in different parts of the body, including the heart, lungs, kidneys and gastrointestinal organs. About 80%-85% of MIS-C cases across the U.S. and Europe have involved the heart's left ventricle.

For more information check out the full story on the link below:

Heart function recovered quickly in children with COVID-19-related MIS-C condition 

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News